Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences to Open New Facility in Florida

NEW YORK (GenomeWeb News) – Becton Dickinson’s BD Biosciences division will open a new manufacturing facility in Miami-Dade County, Florida, according to a statement today from the Beacon Council, the county’s economic development organization.
 
BD will invest more than $20 million in renovating the 90,000-square-feet facility, which formerly belonged to Ivax Pharmaceuticals. The Beacon Council said that the new manufacturing facility is expected to create 75 “high-paying” jobs over the next eight years.
 
BD Biosciences will produce cell media supplements for vaccines and biopharmaceuticals at the new facility.
 
BD qualifies for performance-based incentives of $1.4 million from state and local authorities. The council said these incentives will be paid to BD only if the company meets specific investment and job creation commitments during the next eight years. The incentives include a Florida Qualified Target Industry tax refund and funding from the Miami-Dade County Targeted Jobs Incentive Fund.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more